The Research Landscape
Somatic Experiencing (SE) has emerged as a growing focus within trauma research over the past two decades. The evidence base consists of randomised controlled trials, observational studies, and clinical outcome research conducted across diverse populations experiencing trauma and anxiety-related disorders. The modality is rooted in understanding how the nervous system processes threat: according to SE theory, unresolved traumatic stress becomes encoded in the body as frozen or incomplete defensive responses—what practitioners call activation of the sympathetic or freeze states. Research from neuroscience and trauma psychology has lent credence to this framework, particularly work by researchers like Bessel van der Kolk and others who demonstrate that trauma impacts body-based regulation systems and sensorimotor memory. The current research landscape reflects both promising clinical outcomes and important gaps in rigorous comparative effectiveness research. Most studies are small to moderate in size, and the field continues to call for larger, multi-site trials to establish efficacy across diverse populations. Evidence quality ranges from strong for PTSD and anxiety disorders to moderate for chronic pain, reflecting the modality's primary clinical applications and research investment to date.
Where Evidence Is Strongest
The strongest evidence for Somatic Experiencing centres on PTSD and anxiety-related disorders. A randomised controlled trial published in The Journal of Trauma and Dissociation in 2015 found that SE produced significant reductions in PTSD symptoms, with improvements comparable to other trauma-focused psychotherapies. Participants showed measurable decreases in intrusive memories, hyperarousal, and avoidance—the core PTSD symptom clusters. Clinical outcome studies have similarly documented reductions in panic symptoms and generalised anxiety when individuals engage in body-based nervous system regulation through SE practice. The mechanisms appear to involve the development of greater interoceptive awareness—the ability to notice internal bodily signals—which supports self-regulation and reduces hypervigilance. Research in the neuroscience of trauma supports this: when individuals learn to track and modulate their physiological responses, activation of the amygdala and other threat-detection circuits appears to decrease, allowing greater prefrontal regulation. For practitioners and seekers, this means evidence is reasonably robust for SE as a complement to conventional mental health treatment in PTSD and anxiety disorders. However, most studies involve relatively small samples and few randomised controlled trials have directly compared SE to gold-standard treatments like trauma-focused cognitive behavioural therapy, so the field continues to refine understanding of relative effectiveness and for whom SE works best.
Emerging Areas of Study
Research into Somatic Experiencing is expanding into several promising but less-established areas. Chronic pain and fibromyalgia represent an emerging frontier: preliminary evidence suggests that nervous system dysregulation contributes to pain amplification, and that somatic awareness practices may reduce pain signal intensity. The theory posits that unresolved trauma leaves the nervous system in a chronic state of threat detection, increasing sensitivity to pain stimuli. A handful of small studies have found that SE or similar somatic therapies reduce pain severity and improve functional capacity in fibromyalgia populations, though larger studies are needed. Another emerging application involves substance use recovery and addiction. Early work suggests that SE may support individuals in developing greater awareness of craving sensations and internal states that drive compulsive behaviour, potentially complementing conventional addiction treatment. This aligns with growing recognition that trauma and dysregulation underlie many cases of substance use disorder, but clinical trial evidence specifically for SE in this population remains limited. Researchers are also investigating SE in children and adolescents with trauma exposure, exploring how developmental stage may influence treatment delivery and efficacy. Additionally, workplace resilience and performance enhancement are being studied informally, though rigorous evidence remains preliminary. These emerging areas reflect genuine clinical interest and theoretical plausibility, but seekers should understand that evidence quality is lower than for PTSD and anxiety applications, and consultation with qualified healthcare professionals is especially important when exploring SE for these conditions.
Limitations and Gaps in the Research
Despite growing evidence, significant research gaps remain. The body of SE research consists largely of small to moderate-sized studies, open trials, and non-randomised designs. High-quality randomised controlled trials comparing SE to active control conditions or gold-standard treatments are limited, which makes definitive claims about effectiveness relative to established therapies premature. Study populations have been relatively homogeneous—often white, Western, English-speaking cohorts—limiting generalisability to diverse cultural contexts where trauma and nervous system regulation may be understood and experienced differently. Publication bias may inflate the apparent efficacy of SE, as negative or null findings are less likely to reach publication. Mechanistic research investigating precisely how SE produces change—what aspects of the practice are most therapeutic—remains underdeveloped. Long-term follow-up data are sparse; most studies report outcomes immediately or shortly after treatment without tracking durability over months or years. The field also lacks clear consensus on optimal dose, session frequency, and duration, making it difficult for seekers to have evidence-informed expectations about treatment intensity. Finally, very few studies have examined potential harms or adverse effects, though qualitative reports suggest that somatic processing can temporarily intensify emotional or physical sensations in vulnerable individuals. These limitations do not invalidate the evidence that exists, but they underscore the importance of viewing SE as a complementary, not replacement, modality and of seeking integrated care with qualified healthcare professionals, particularly for serious or complex conditions.
What This Means for You
If you are considering Somatic Experiencing, the current evidence landscape offers reasonably solid support for trying the modality as part of a comprehensive trauma recovery or anxiety management plan—particularly for PTSD, generalised anxiety, or panic disorder. The research suggests that SE can help you develop greater awareness of bodily sensations and nervous system states, supporting self-regulation and reducing the intensity of trauma or anxiety symptoms. However, SE works best alongside conventional mental health treatment, not instead of it. If you are currently on psychiatric medication, continue taking it as prescribed; if you are in therapy, discuss adding SE with your mental health provider to ensure coordinated care. For emerging applications like chronic pain or fibromyalgia, evidence is promising but less definitive, so set realistic expectations and discuss how SE might complement other pain management approaches. When seeking a practitioner, prioritise those with formal training and certification through organisations like Somatic Experiencing International, which ensures foundational competence in trauma neurobiology and ethical practice standards. Be transparent about your symptoms, trauma history, and any psychiatric or medical conditions so your practitioner can tailor the approach appropriately and identify any contraindications. Finally, understand that while research supports nervous system regulation as therapeutic, the field continues to evolve. Staying informed about evidence and maintaining open dialogue with your healthcare team will help you make the most informed decisions about whether and how Somatic Experiencing fits into your healing journey.








